Comparison of the Effect of Ranibizumab and Verteporfin for Polypoidal Choroidal Vasculopathy: 12-Month LAPTOP Study Results
Authors:
- Akio OishiAkio Oishi
- Hiroshi KojimaHKHiroshi Kojima
- Michiko MandaiMMMichiko Mandai
- Shigeru HondaSHShigeru Honda
- Toshiyuki MatsuokaTMToshiyuki Matsuoka
- Hideyasu OhHOHideyasu Oh
- Mihori KitaMKMihori Kita
- Tomoko NagaiTNTomoko Nagai
- Masashi FujiharaMFMasashi Fujihara
- Nobuhiro BesshoNBNobuhiro Bessho
- Mamoru UenishiMUMamoru Uenishi
- Yasuo KurimotoYKYasuo Kurimoto
- 1 October 2013
- journal article
- research article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 156 (4) , 644-651.e1
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science (22791706)
This publication has 50 references indexed in Scilit:
- Results of 2 years of treatment with as-needed ranibizumab reinjection for polypoidal choroidal vasculopathyBritish Journal of Ophthalmology, 2013
- Verteporfin plus Ranibizumab for Choroidal Neovascularization in Age-related Macular DegenerationOphthalmology, 2012
- Intravitreal bevacizumab and ranibizumab injections for patients with polypoidal choroidal vasculopathyEye, 2011
- One-Year Results of Intravitreal Ranibizumab with or without Photodynamic Therapy for Polypoidal Choroidal VasculopathyOphthalmologica, 2011
- Ranibizumab and Bevacizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2011
- ONE-YEAR OUTCOMES OF INTRAVITREAL BEVACIZUMAB (AVASTIN) THERAPY FOR POLYPOIDAL CHOROIDAL VASCULOPATHYRetina, 2011
- Photodynamic therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathy: A 30-month multicenter study in Hyogo, JapanJapanese Journal of Ophthalmology, 2009
- Comparative Assessment of Photodynamic Therapy for Typical Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy: A Multicenter Study in Hyogo Prefecture, JapanOphthalmologica, 2009
- Short-Term Safety and Efficacy of a Single Intravitreal Bevacizumab Injection for the Management of Polypoidal Choroidal VasculopathyOphthalmologica, 2008
- Ranibizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006